A Cross-sectional Study of Ocular Manifestations During the Covid-19 Pandemic in Hubei Province
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 16,000
- 试验地点
- 1
- 主要终点
- Questionnaire data were collected and statistically analyzed.
研究概览
简要总结
To investigate the clinical features of ocular manifestations during the novel coronavirus pneumonia pandemic in Hubei at the end of 2022
详细描述
During late 2022 COVID-19 pandemic ocular discomforts were common in people with mild systemic symptoms, but most resolve on their own without any treatment. The disease spectrum of ophthalmology outpatient clinics is affected by the COVID-19 pandemic. In our study, we observed that the incidence of keratitis and acute angle-closure glaucoma in Phase A was significantly higher than that in Phase B and C.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •2022.12.7 to 2023.2.6 People surveyed by wechat Questionnaire Star
- •2021.12.7 to 2022.1.6 and 2022.11.7 to 2023.1.6 Patients who received ophthalmology treatment in Zhongnan Hospital of Wuhan University and Qichun People's Hospital
排除标准
- •currently hospitalized patients.
- •severe patients.
- •Incomplete information.
- •cannot be contacted by telephone.
- •Refuse questionnaire survey. 6.The electronic medical record information is incomplete.
- •Those who do not go to the ophthalmic clinic after registration. 8.severe patients.
- •Cannot be contacted by phone.
结局指标
主要结局
Questionnaire data were collected and statistically analyzed.
时间窗: 1/4/2024-30/4/2024
Information on demographic characteristics, COVID-19 pathogen test results, Covid-19 related systemic symptoms, ocular symptoms and eye discomfort medication was collected from questionnaires during the pandemic period (Phase A: December 7, 2022 to January 6, 2023, 1968 patients). Electronic medical records in the ophthalmic outpatient department of Zhongnan Hospital of Wuhan University and its medical union hospital- Qichun County People's Hospital were extracted during the pandemic period (Phase A) and the prevention and control periods (Phase B: November 7, 2022 to December 6, 2022 and Phase C: December 7, 2021 to January 6, 2022). The demographic, epidemiological, and clinical information of patients were compared.
次要结局
未报告次要终点
研究者
Min Ke
Director of Ophthalmology
Zhongnan Hospital